Skip to main content
Erschienen in: Current Hypertension Reports 1/2018

01.01.2018 | Implementation to Increase Blood Pressure Control: What Works? (J Brettler and K Reynolds, Section Editors)

Implementing ABPM into Clinical Practice

verfasst von: Alan L. Hinderliter, Raven A. Voora, Anthony J. Viera

Erschienen in: Current Hypertension Reports | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

To review the data supporting the use of ambulatory blood pressure monitoring (ABPM), and to provide practical guidance for practitioners who are establishing an ambulatory monitoring service.

Recent Findings

ABPM results more accurately reflect the risk of cardiovascular events than do office measurements of blood pressure. Moreover, many patients with high blood pressure in the office have normal blood pressure on ABPM—a pattern known as white coat hypertension—and have a prognosis similar to individuals who are normotensive in both settings. For these reasons, ABPM is recommended by the US Preventive Services Task Force to confirm the diagnosis of hypertension in patients with high office blood pressure before medical therapy is initiated. Similarly, the 2017 ACC/AHA High Blood Pressure Clinical Practice Guideline advocates the use of out-of-office blood pressure measurements to confirm hypertension and evaluate the efficacy of blood pressure-lowering medications. In addition to white coat hypertension, blood pressure phenotypes that are associated with increased cardiovascular risk and that can be recognized by ABPM include masked hypertension—characterized by normal office blood pressure but high values on ABPM—and high nocturnal blood pressure. In this review, best practices for starting a clinical ABPM service, performing an ABPM monitoring session, and interpreting and reporting ABPM data are described.

Summary

ABPM is a valuable adjunct to careful office blood pressure measurement in diagnosing hypertension and in guiding antihypertensive therapy. Following recommended best practices can facilitate implementation of ABPM into clinical practice.
Literatur
1.
Zurück zum Zitat •• Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Hypertension. 2017. https://doi.org/10.1161/HYP.0000000000000065. This comprehensive guideline statement, which will have a major influence on the evaluation and management of hypertension in the USA, emphasizes the importance of out-of-office blood pressure measurement in establishing the diagnosis of hypertension and in assessing the effects of therapy. •• Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Hypertension. 2017. https://​doi.​org/​10.​1161/​HYP.​0000000000000065​. This comprehensive guideline statement, which will have a major influence on the evaluation and management of hypertension in the USA, emphasizes the importance of out-of-office blood pressure measurement in establishing the diagnosis of hypertension and in assessing the effects of therapy.
3.
Zurück zum Zitat Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010;303:2043–50.CrossRefPubMed Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010;303:2043–50.CrossRefPubMed
4.
Zurück zum Zitat Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mmHg, 1990–2015. JAMA. 2017;317:165–82.CrossRefPubMed Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mmHg, 1990–2015. JAMA. 2017;317:165–82.CrossRefPubMed
5.
Zurück zum Zitat Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation. 2005;111:697–716.CrossRefPubMed Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation. 2005;111:697–716.CrossRefPubMed
6.
Zurück zum Zitat McKay DW, Raju MK, Campbell NR. Assessment of blood pressure measuring techniques. Med Educ. 1992;26:208–12.CrossRefPubMed McKay DW, Raju MK, Campbell NR. Assessment of blood pressure measuring techniques. Med Educ. 1992;26:208–12.CrossRefPubMed
7.
Zurück zum Zitat Powers BJ, Olsen MK, Smith VA, Woolson RF, Bosworth HB, Oddone EZ. Measuring blood pressure for decision making and quality reporting: where and how many measures? Ann Intern Med. 2011;154:781–8. NaN-289–90CrossRefPubMed Powers BJ, Olsen MK, Smith VA, Woolson RF, Bosworth HB, Oddone EZ. Measuring blood pressure for decision making and quality reporting: where and how many measures? Ann Intern Med. 2011;154:781–8. NaN-289–90CrossRefPubMed
8.
Zurück zum Zitat Fagard RH, Van Den Broeke C, De Cort P. Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice. J Hum Hypertens. 2005;19:801–7.CrossRefPubMed Fagard RH, Van Den Broeke C, De Cort P. Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice. J Hum Hypertens. 2005;19:801–7.CrossRefPubMed
9.
Zurück zum Zitat Ohkubo T, Imai Y, Tsuji I, Nagai K, Kato J, Kikuchi N, et al. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohasama. Japan J Hypertens. 1998;16:971–5.CrossRefPubMed Ohkubo T, Imai Y, Tsuji I, Nagai K, Kato J, Kikuchi N, et al. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohasama. Japan J Hypertens. 1998;16:971–5.CrossRefPubMed
10.
Zurück zum Zitat Asayama K, Ohkubo T, Kikuya M, Obara T, Metoki H, Inoue R, et al. Prediction of stroke by home “morning” versus “evening” blood pressure values: the Ohasama study. Hypertens (Dallas, Tex. 1979). 2006;48:737–43.CrossRef Asayama K, Ohkubo T, Kikuya M, Obara T, Metoki H, Inoue R, et al. Prediction of stroke by home “morning” versus “evening” blood pressure values: the Ohasama study. Hypertens (Dallas, Tex. 1979). 2006;48:737–43.CrossRef
11.
Zurück zum Zitat Niiranen TJ, Hänninen M-R, Johansson J, Reunanen A, Jula AM. Home-measured blood pressure is a stronger predictor of cardiovascular risk than office blood pressure: the Finn-Home study. Hypertens (Dallas, Tex. 1979). 2010;55:1346–51.CrossRef Niiranen TJ, Hänninen M-R, Johansson J, Reunanen A, Jula AM. Home-measured blood pressure is a stronger predictor of cardiovascular risk than office blood pressure: the Finn-Home study. Hypertens (Dallas, Tex. 1979). 2010;55:1346–51.CrossRef
12.
Zurück zum Zitat Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertens (Dallas, Tex. 1979). 2005;46:156–61.CrossRef Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertens (Dallas, Tex. 1979). 2005;46:156–61.CrossRef
13.
Zurück zum Zitat Gasowski J, Li Y, Kuznetsova T, Richart T, Thijs L, Grodzicki T, et al. Is “usual” blood pressure a proxy for 24-h ambulatory blood pressure in predicting cardiovascular outcomes? Am J Hypertens. 2008;21:994–1000.CrossRefPubMed Gasowski J, Li Y, Kuznetsova T, Richart T, Thijs L, Grodzicki T, et al. Is “usual” blood pressure a proxy for 24-h ambulatory blood pressure in predicting cardiovascular outcomes? Am J Hypertens. 2008;21:994–1000.CrossRefPubMed
14.
Zurück zum Zitat Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med. 2003;348:2407–15.CrossRefPubMed Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med. 2003;348:2407–15.CrossRefPubMed
15.
Zurück zum Zitat Hermida RC, Ayala DE, Mojón A, Fernández JR. Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk. J Am Coll Cardiol. 2011;58:1165–73.CrossRefPubMed Hermida RC, Ayala DE, Mojón A, Fernández JR. Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk. J Am Coll Cardiol. 2011;58:1165–73.CrossRefPubMed
16.
Zurück zum Zitat Mesquita-Bastos J, Bertoquini S, Polónia J. Cardiovascular prognostic value of ambulatory blood pressure monitoring in a Portuguese hypertensive population followed up for 8.2 years. Blood Press Monit. 2010;15:240–6.CrossRefPubMed Mesquita-Bastos J, Bertoquini S, Polónia J. Cardiovascular prognostic value of ambulatory blood pressure monitoring in a Portuguese hypertensive population followed up for 8.2 years. Blood Press Monit. 2010;15:240–6.CrossRefPubMed
17.
Zurück zum Zitat Staessen JA, Thijs L, Fagard R, O’Brien ET, Clement D, de Leeuw PW, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic hypertension in Europe trial investigators. JAMA. 1999;282:539–46.CrossRefPubMed Staessen JA, Thijs L, Fagard R, O’Brien ET, Clement D, de Leeuw PW, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic hypertension in Europe trial investigators. JAMA. 1999;282:539–46.CrossRefPubMed
18.
Zurück zum Zitat •• Siu AL, U.S. Preventive Services Task Force. Screening for high blood pressure in adults: U.S. preventive services task force recommendation statement. Ann Intern Med. 2015;163:778–86. This statement from the US Preventive Services Task Force recommends out-of-office blood pressure monitoring to confirm a diagnosis of hypertension before starting treatment. ABPM is recognized as the best method for diagnosing hypertension. CrossRefPubMed •• Siu AL, U.S. Preventive Services Task Force. Screening for high blood pressure in adults: U.S. preventive services task force recommendation statement. Ann Intern Med. 2015;163:778–86. This statement from the US Preventive Services Task Force recommends out-of-office blood pressure monitoring to confirm a diagnosis of hypertension before starting treatment. ABPM is recognized as the best method for diagnosing hypertension. CrossRefPubMed
19.
Zurück zum Zitat Krause T, Lovibond K, Caulfield M, McCormack T, Williams B. Management of hypertension: summary of NICE guidance. BMJ. 2011;343:d4891–1. Krause T, Lovibond K, Caulfield M, McCormack T, Williams B. Management of hypertension: summary of NICE guidance. BMJ. 2011;343:d4891–1.
20.
Zurück zum Zitat •• O’Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G, et al. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31:1731–68. This position paper is a comprehensive review of ABPM, describing devices and software, procedures, indications for monitoring, and strategies for implementation. CrossRefPubMed •• O’Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G, et al. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31:1731–68. This position paper is a comprehensive review of ABPM, describing devices and software, procedures, indications for monitoring, and strategies for implementation. CrossRefPubMed
21.
Zurück zum Zitat Weber MA, Schiffrin EL, White WB, Mann S, Lindholm LH, Kenerson JG, et al. Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens (Greenwich). 2014;16:14–26.CrossRef Weber MA, Schiffrin EL, White WB, Mann S, Lindholm LH, Kenerson JG, et al. Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens (Greenwich). 2014;16:14–26.CrossRef
22.
Zurück zum Zitat Leung AA, Daskalopoulou SS, Dasgupta K, McBrien K, Butalia S, Zarnke KB, et al. Hypertension Canada’s 2017 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults. Can J Cardiol. 2017;33:557–76.CrossRefPubMed Leung AA, Daskalopoulou SS, Dasgupta K, McBrien K, Butalia S, Zarnke KB, et al. Hypertension Canada’s 2017 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults. Can J Cardiol. 2017;33:557–76.CrossRefPubMed
23.
Zurück zum Zitat Aronow WS, Fleg JL, Pepine CJ, Artinian NT, Bakris G, Brown AS, et al. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension. J Am Coll Cardiol. 2011;57:2037–114.CrossRefPubMed Aronow WS, Fleg JL, Pepine CJ, Artinian NT, Bakris G, Brown AS, et al. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension. J Am Coll Cardiol. 2011;57:2037–114.CrossRefPubMed
24.
Zurück zum Zitat Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC guidelines for the Management of Arterial Hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34:2159–219.CrossRefPubMed Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC guidelines for the Management of Arterial Hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34:2159–219.CrossRefPubMed
25.
Zurück zum Zitat Viera AJ, Lingley K, Hinderliter AL. Tolerability of the Oscar 2 ambulatory blood pressure monitor among research participants: a cross-sectional repeated measures study. BMC Med Res Methodol. 2011;11:59.CrossRefPubMedPubMedCentral Viera AJ, Lingley K, Hinderliter AL. Tolerability of the Oscar 2 ambulatory blood pressure monitor among research participants: a cross-sectional repeated measures study. BMC Med Res Methodol. 2011;11:59.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat O’Brien E, Atkins N, Stergiou G, Karpettas N, Parati G, Asmar R, et al. European Society of Hypertension International Protocol revision 2010 for the validation of blood pressure measuring devices in adults. Blood Press Monit. 2010;15:23–38.CrossRefPubMed O’Brien E, Atkins N, Stergiou G, Karpettas N, Parati G, Asmar R, et al. European Society of Hypertension International Protocol revision 2010 for the validation of blood pressure measuring devices in adults. Blood Press Monit. 2010;15:23–38.CrossRefPubMed
27.
Zurück zum Zitat O’Brien E, Petrie J, Littler W, de Swiet M, Padfield PL, Altman DG, et al. An outline of the revised British hypertension society protocol for the evaluation of blood pressure measuring devices. J Hypertens. 1993;11:677–9.CrossRefPubMed O’Brien E, Petrie J, Littler W, de Swiet M, Padfield PL, Altman DG, et al. An outline of the revised British hypertension society protocol for the evaluation of blood pressure measuring devices. J Hypertens. 1993;11:677–9.CrossRefPubMed
28.
Zurück zum Zitat Association for the Advancement of Medical Instrumentation. Manual, electronic, or automated sphygmomanometers: AASI/AAMI SP10–2002. Arlington: Association for the Advancement of Medical Instrumentation; 2003. Association for the Advancement of Medical Instrumentation. Manual, electronic, or automated sphygmomanometers: AASI/AAMI SP10–2002. Arlington: Association for the Advancement of Medical Instrumentation; 2003.
29.
Zurück zum Zitat •• Parati G, Stergiou G, O’Brien E, Asmar R, Beilin L, Bilo G, et al. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens. 2014;32:1359–66. This is a concise summary of the important aspects of using ABPM in clinical practice. CrossRefPubMed •• Parati G, Stergiou G, O’Brien E, Asmar R, Beilin L, Bilo G, et al. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens. 2014;32:1359–66. This is a concise summary of the important aspects of using ABPM in clinical practice. CrossRefPubMed
30.
Zurück zum Zitat •• Shimbo D, Abdalla M, Falzon L, Townsend RR, Muntner P. Role of ambulatory and home blood pressure monitoring in clinical practice: a narrative review. Ann Intern Med. 2015;163:691–700. This very useful review describes both ABPM and home blood pressure monitoring. CrossRefPubMedPubMedCentral •• Shimbo D, Abdalla M, Falzon L, Townsend RR, Muntner P. Role of ambulatory and home blood pressure monitoring in clinical practice: a narrative review. Ann Intern Med. 2015;163:691–700. This very useful review describes both ABPM and home blood pressure monitoring. CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Turner JR, Viera AJ, Shimbo D. Ambulatory blood pressure monitoring in clinical practice: a review. Am J Med. 2015;128:14–20.CrossRefPubMed Turner JR, Viera AJ, Shimbo D. Ambulatory blood pressure monitoring in clinical practice: a review. Am J Med. 2015;128:14–20.CrossRefPubMed
32.
Zurück zum Zitat Pickering TG, White WB, Giles TD, Black HR, Izzo JL, Materson BJ, et al. When and how to use self (home) and ambulatory blood pressure monitoring. J Am Soc Hypertens. 2010;4:56–61.CrossRefPubMed Pickering TG, White WB, Giles TD, Black HR, Izzo JL, Materson BJ, et al. When and how to use self (home) and ambulatory blood pressure monitoring. J Am Soc Hypertens. 2010;4:56–61.CrossRefPubMed
33.
Zurück zum Zitat White WB, Gulati V. Managing hypertension with ambulatory blood pressure monitoring. Curr Cardiol Rep. 2015;17:2.CrossRefPubMed White WB, Gulati V. Managing hypertension with ambulatory blood pressure monitoring. Curr Cardiol Rep. 2015;17:2.CrossRefPubMed
34.
Zurück zum Zitat Pickering TG, White WB, American Society of Hypertension Writing Group. ASH position paper: home and ambulatory blood pressure monitoring. When and how to use self (home) and ambulatory blood pressure monitoring. J Clin Hypertens (Greenwich). 2008;10:850–5.CrossRef Pickering TG, White WB, American Society of Hypertension Writing Group. ASH position paper: home and ambulatory blood pressure monitoring. When and how to use self (home) and ambulatory blood pressure monitoring. J Clin Hypertens (Greenwich). 2008;10:850–5.CrossRef
35.
Zurück zum Zitat Kikuya M, Hansen TW, Thijs L, Björklund-Bodegård K, Kuznetsova T, Ohkubo T, et al. Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk. Circulation. 2007;115:2145–52.CrossRefPubMed Kikuya M, Hansen TW, Thijs L, Björklund-Bodegård K, Kuznetsova T, Ohkubo T, et al. Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk. Circulation. 2007;115:2145–52.CrossRefPubMed
36.
Zurück zum Zitat Winnicki M, Canali C, Mormino P, Palatini P. Ambulatory blood pressure monitoring editing criteria: is standardization needed? Hypertension and Ambulatory Recording Venetia study (HARVEST) group. Italy Am J Hypertens. 1997;10:419–27.PubMed Winnicki M, Canali C, Mormino P, Palatini P. Ambulatory blood pressure monitoring editing criteria: is standardization needed? Hypertension and Ambulatory Recording Venetia study (HARVEST) group. Italy Am J Hypertens. 1997;10:419–27.PubMed
37.
Zurück zum Zitat Booth JN, Muntner P, Abdalla M, Diaz KM, Viera AJ, Reynolds K, et al. Differences in night-time and daytime ambulatory blood pressure when diurnal periods are defined by self-report, fixed-times, and actigraphy: improving the detection of hypertension study. J Hypertens. 2016;34:235–43.CrossRefPubMedPubMedCentral Booth JN, Muntner P, Abdalla M, Diaz KM, Viera AJ, Reynolds K, et al. Differences in night-time and daytime ambulatory blood pressure when diurnal periods are defined by self-report, fixed-times, and actigraphy: improving the detection of hypertension study. J Hypertens. 2016;34:235–43.CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat O’Brien E, Asmar R, Beilin L, Imai Y, Mancia G, Mengden T, et al. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens. 2005;23:697–701.CrossRefPubMed O’Brien E, Asmar R, Beilin L, Imai Y, Mancia G, Mengden T, et al. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens. 2005;23:697–701.CrossRefPubMed
39.
Zurück zum Zitat • Ravenell J, Shimbo D, Booth JN, Sarpong DF, Agyemang C, Beatty Moody DL, et al. Thresholds for ambulatory blood pressure among African Americans in the Jackson heart study. Circulation. 2017;135:2470–80. This analysis of data from the Jackson Heart Study suggests that slightly higher ambulatory blood pressure thresholds to define hypertension may be appropriate in African-Americans. CrossRefPubMed • Ravenell J, Shimbo D, Booth JN, Sarpong DF, Agyemang C, Beatty Moody DL, et al. Thresholds for ambulatory blood pressure among African Americans in the Jackson heart study. Circulation. 2017;135:2470–80. This analysis of data from the Jackson Heart Study suggests that slightly higher ambulatory blood pressure thresholds to define hypertension may be appropriate in African-Americans. CrossRefPubMed
40.
Zurück zum Zitat Krause T, Lovibond K, Caulfield M, McCormack T, Williams B. Guideline Development Group. Management of hypertension: summary of NICE guidance BMJ. 2011;343:d4891.PubMed Krause T, Lovibond K, Caulfield M, McCormack T, Williams B. Guideline Development Group. Management of hypertension: summary of NICE guidance BMJ. 2011;343:d4891.PubMed
41.
Zurück zum Zitat • Franklin SS, Thijs L, Asayama K, Li Y, Hansen TW, Boggia J, et al. The cardiovascular risk of white-coat hypertension. J Am Coll Cardiol. 2016;68:2033–43. This careful analysis of IDACO data found that cardiovascular risk in most persons with white-coat hypertension is comparable to age- and risk-adjusted normotensive control subjects. CrossRefPubMed • Franklin SS, Thijs L, Asayama K, Li Y, Hansen TW, Boggia J, et al. The cardiovascular risk of white-coat hypertension. J Am Coll Cardiol. 2016;68:2033–43. This careful analysis of IDACO data found that cardiovascular risk in most persons with white-coat hypertension is comparable to age- and risk-adjusted normotensive control subjects. CrossRefPubMed
42.
Zurück zum Zitat Fagard RH, Staessen JA, Thijs L, Gasowski J, Bulpitt CJ, Clement D, et al. Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Systolic hypertension in Europe (Syst-Eur) trial investigators. Circulation. 2000;102:1139–44.CrossRefPubMed Fagard RH, Staessen JA, Thijs L, Gasowski J, Bulpitt CJ, Clement D, et al. Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Systolic hypertension in Europe (Syst-Eur) trial investigators. Circulation. 2000;102:1139–44.CrossRefPubMed
43.
Zurück zum Zitat Kario K, Shimada K, Schwartz JE, Matsuo T, Hoshide S, Pickering TG. Silent and clinically overt stroke in older Japanese subjects with white-coat and sustained hypertension. J Am Coll Cardiol. 2001;38:238–45.CrossRefPubMed Kario K, Shimada K, Schwartz JE, Matsuo T, Hoshide S, Pickering TG. Silent and clinically overt stroke in older Japanese subjects with white-coat and sustained hypertension. J Am Coll Cardiol. 2001;38:238–45.CrossRefPubMed
44.
Zurück zum Zitat Khattar RS, Senior R, Lahiri A. Cardiovascular outcome in white-coat versus sustained mild hypertension: a 10-year follow-up study. Circulation. 1998;98:1892–7.CrossRefPubMed Khattar RS, Senior R, Lahiri A. Cardiovascular outcome in white-coat versus sustained mild hypertension: a 10-year follow-up study. Circulation. 1998;98:1892–7.CrossRefPubMed
45.
Zurück zum Zitat Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertens (Dallas, Tex. 1979). 2006;47:846–53.CrossRef Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertens (Dallas, Tex. 1979). 2006;47:846–53.CrossRef
46.
Zurück zum Zitat •• Piper MA, Evans CV, Burda BU, Margolis KL, O’Connor E, Whitlock EP. Diagnostic and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2015;162:192–204. This systematic review of ABPM and home blood pressure monitoring in comparison to office blood pressure provides the basis for the US Preventive Services Task Force recommendation to perform out-of-office measurements to confirm the diagnosis of hypertension. CrossRefPubMed •• Piper MA, Evans CV, Burda BU, Margolis KL, O’Connor E, Whitlock EP. Diagnostic and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2015;162:192–204. This systematic review of ABPM and home blood pressure monitoring in comparison to office blood pressure provides the basis for the US Preventive Services Task Force recommendation to perform out-of-office measurements to confirm the diagnosis of hypertension. CrossRefPubMed
47.
Zurück zum Zitat de la Sierra A, Segura J, Banegas JR, Gorostidi M, de la Cruz JJ, Armario P, et al. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertens (Dallas, Tex. 1979). 2011;57:898–902.CrossRef de la Sierra A, Segura J, Banegas JR, Gorostidi M, de la Cruz JJ, Armario P, et al. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertens (Dallas, Tex. 1979). 2011;57:898–902.CrossRef
48.
Zurück zum Zitat Muxfeldt ES, Bloch KV, Nogueira Ada R, Salles GF. True resistant hypertension: is it possible to be recognized in the office? Am J Hypertens. 2005;18:1534–40.CrossRefPubMed Muxfeldt ES, Bloch KV, Nogueira Ada R, Salles GF. True resistant hypertension: is it possible to be recognized in the office? Am J Hypertens. 2005;18:1534–40.CrossRefPubMed
49.
Zurück zum Zitat Brown MA, Buddle ML, Martin A. Is resistant hypertension really resistant? Am J Hypertens. 2001;14:1263–9.CrossRefPubMed Brown MA, Buddle ML, Martin A. Is resistant hypertension really resistant? Am J Hypertens. 2001;14:1263–9.CrossRefPubMed
50.
Zurück zum Zitat Franklin SS, Thijs L, Hansen TW, Li Y, Boggia J, Kikuya M, et al. Significance of white-coat hypertension in older persons with isolated systolic hypertension: a meta-analysis using the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes population. Hypertens (Dallas, Tex. 1979). 2012;59:564–71.CrossRef Franklin SS, Thijs L, Hansen TW, Li Y, Boggia J, Kikuya M, et al. Significance of white-coat hypertension in older persons with isolated systolic hypertension: a meta-analysis using the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes population. Hypertens (Dallas, Tex. 1979). 2012;59:564–71.CrossRef
51.
Zurück zum Zitat Björklund K, Lind L, Zethelius B, Andrén B, Lithell H. Isolated ambulatory hypertension predicts cardiovascular morbidity in elderly men. Circulation. 2003;107:1297–302.CrossRefPubMed Björklund K, Lind L, Zethelius B, Andrén B, Lithell H. Isolated ambulatory hypertension predicts cardiovascular morbidity in elderly men. Circulation. 2003;107:1297–302.CrossRefPubMed
52.
Zurück zum Zitat Hansen TW, Jeppesen J, Rasmussen S, Ibsen H, Torp-Pedersen C. Ambulatory blood pressure monitoring and risk of cardiovascular disease: a population based study. Am J Hypertens. 2006;19:243–50.CrossRefPubMed Hansen TW, Jeppesen J, Rasmussen S, Ibsen H, Torp-Pedersen C. Ambulatory blood pressure monitoring and risk of cardiovascular disease: a population based study. Am J Hypertens. 2006;19:243–50.CrossRefPubMed
53.
Zurück zum Zitat Ohkubo T, Kikuya M, Metoki H, Asayama K, Obara T, Hashimoto J, et al. Prognosis of “masked” hypertension and “white-coat” hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol. 2005;46:508–15.CrossRefPubMed Ohkubo T, Kikuya M, Metoki H, Asayama K, Obara T, Hashimoto J, et al. Prognosis of “masked” hypertension and “white-coat” hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol. 2005;46:508–15.CrossRefPubMed
54.
Zurück zum Zitat Diaz KM, Veerabhadrappa P, Brown MD, Whited MC, Dubbert PM, Hickson DA. Prevalence, determinants, and clinical significance of masked hypertension in a population-based sample of African Americans: the Jackson heart study. Am J Hypertens. 2015;28:900–8.CrossRefPubMed Diaz KM, Veerabhadrappa P, Brown MD, Whited MC, Dubbert PM, Hickson DA. Prevalence, determinants, and clinical significance of masked hypertension in a population-based sample of African Americans: the Jackson heart study. Am J Hypertens. 2015;28:900–8.CrossRefPubMed
55.
Zurück zum Zitat Viera AJ, Lin F-C, Tuttle LA, Olsson E, Stankevitz K, Girdler SS, et al. Reproducibility of masked hypertension among adults 30 years or older. Blood Press Monit. 2014;19:208–15. Viera AJ, Lin F-C, Tuttle LA, Olsson E, Stankevitz K, Girdler SS, et al. Reproducibility of masked hypertension among adults 30 years or older. Blood Press Monit. 2014;19:208–15.
56.
Zurück zum Zitat Salles GF, Reboldi G, Fagard RH, Cardoso CRL, Pierdomenico SD, Verdecchia P, et al. Prognostic effect of the nocturnal blood pressure fall in hypertensive patients: the Ambulatory Blood Pressure Collaboration in Patients with Hypertension (ABC-H) meta-analysis. Hypertens (Dallas, Tex. 1979). 2016;67:693–700.CrossRef Salles GF, Reboldi G, Fagard RH, Cardoso CRL, Pierdomenico SD, Verdecchia P, et al. Prognostic effect of the nocturnal blood pressure fall in hypertensive patients: the Ambulatory Blood Pressure Collaboration in Patients with Hypertension (ABC-H) meta-analysis. Hypertens (Dallas, Tex. 1979). 2016;67:693–700.CrossRef
57.
Zurück zum Zitat Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Björklund-Bodegård K, et al. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet (London, England). 2007;370:1219–29.CrossRef Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Björklund-Bodegård K, et al. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet (London, England). 2007;370:1219–29.CrossRef
58.
Zurück zum Zitat Li Y, Thijs L, Hansen TW, Kikuya M, Boggia J, Richart T, et al. Prognostic value of the morning blood pressure surge in 5645 subjects from 8 populations. Hypertens (Dallas, Tex. 1979). 2010;55:1040–8.CrossRef Li Y, Thijs L, Hansen TW, Kikuya M, Boggia J, Richart T, et al. Prognostic value of the morning blood pressure surge in 5645 subjects from 8 populations. Hypertens (Dallas, Tex. 1979). 2010;55:1040–8.CrossRef
59.
Zurück zum Zitat Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation. 2003;107:1401–6.CrossRefPubMed Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation. 2003;107:1401–6.CrossRefPubMed
60.
Zurück zum Zitat Hansen TW, Thijs L, Li Y, Boggia J, Kikuya M, Björklund-Bodegård K, et al. Prognostic value of reading-to-reading blood pressure variability over 24 hours in 8938 subjects from 11 populations. Hypertens (Dallas, Tex. 1979). 2010;55:1049–57.CrossRef Hansen TW, Thijs L, Li Y, Boggia J, Kikuya M, Björklund-Bodegård K, et al. Prognostic value of reading-to-reading blood pressure variability over 24 hours in 8938 subjects from 11 populations. Hypertens (Dallas, Tex. 1979). 2010;55:1049–57.CrossRef
61.
Zurück zum Zitat Hinderliter AL, Routledge FS, Blumenthal JA, Koch G, Hussey MA, Wohlgemuth WK, et al. Reproducibility of blood pressure dipping: relation to day-to-day variability in sleep quality. J Am Soc Hypertens. 2013;7:432–9. Hinderliter AL, Routledge FS, Blumenthal JA, Koch G, Hussey MA, Wohlgemuth WK, et al. Reproducibility of blood pressure dipping: relation to day-to-day variability in sleep quality. J Am Soc Hypertens. 2013;7:432–9.
62.
Zurück zum Zitat Thijs L, Staessen J, Fagard R, Zachariah P, Amery A. Number of measurements required for the analysis of diurnal blood pressure profile. J Hum Hypertens. 1994;8:239–44.PubMed Thijs L, Staessen J, Fagard R, Zachariah P, Amery A. Number of measurements required for the analysis of diurnal blood pressure profile. J Hum Hypertens. 1994;8:239–44.PubMed
63.
Zurück zum Zitat Kent ST, Shimbo D, Huang L, Diaz KM, Viera AJ, Kilgore M, et al. Rates, amounts, and determinants of ambulatory blood pressure monitoring claim reimbursements among Medicare beneficiaries. J Am Soc Hypertens. 2014;8:898–908.CrossRefPubMedPubMedCentral Kent ST, Shimbo D, Huang L, Diaz KM, Viera AJ, Kilgore M, et al. Rates, amounts, and determinants of ambulatory blood pressure monitoring claim reimbursements among Medicare beneficiaries. J Am Soc Hypertens. 2014;8:898–908.CrossRefPubMedPubMedCentral
64.
Zurück zum Zitat Lovibond K, Jowett S, Barton P, Caulfield M, Heneghan C, Hobbs FDR, et al. Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study. Lancet (London, England). 2011;378:1219–30.CrossRef Lovibond K, Jowett S, Barton P, Caulfield M, Heneghan C, Hobbs FDR, et al. Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study. Lancet (London, England). 2011;378:1219–30.CrossRef
65.
Zurück zum Zitat Myers MG. Automated office blood pressure—the preferred method for recording blood pressure. J Am Soc Hypertens. 2016;10:194–6.CrossRefPubMed Myers MG. Automated office blood pressure—the preferred method for recording blood pressure. J Am Soc Hypertens. 2016;10:194–6.CrossRefPubMed
Metadaten
Titel
Implementing ABPM into Clinical Practice
verfasst von
Alan L. Hinderliter
Raven A. Voora
Anthony J. Viera
Publikationsdatum
01.01.2018
Verlag
Springer US
Erschienen in
Current Hypertension Reports / Ausgabe 1/2018
Print ISSN: 1522-6417
Elektronische ISSN: 1534-3111
DOI
https://doi.org/10.1007/s11906-018-0805-y

Weitere Artikel der Ausgabe 1/2018

Current Hypertension Reports 1/2018 Zur Ausgabe

Secondary Hypertension: Nervous System Mechanisms (M Wyss, Section Editor)

Pheochromocytomas and Hypertension

Secondary Hypertension: Nervous System Mechanisms (M Wyss, Section Editor)

The Interactions of the Immune System and the Brain in Hypertension

Hypertension and Emergency Medicine (T Rainer and P Levy, Section Editors)

Optimizing Hypertensive Acute Heart Failure Management with Afterload Reduction

Hypertension and Emergency Medicine (T Rainer and P Levy, Section Editors)

Sympathomimetic Toxidromes and Other Pharmacological Causes of Acute Hypertension

Implementation to Increase Blood Pressure Control: What Works? (J Brettler and K Reynolds, Section Editors)

Team-Based Care with Pharmacists to Improve Blood Pressure: a Review of Recent Literature

Hypertension and Obesity (E Reisin, Section Editor)

Role of Thioredoxin in Age-Related Hypertension

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

NSCLC: Progressionsfreies Überleben unter Osimertinib fast versiebenfacht

06.06.2024 ASCO 2024 Kongressbericht

Erste Ergebnisse der Phase-III-Studie LAURA etablieren Osimertinib als neuen Therapiestandard für Menschen mit nicht-resezierbarem, EGFR-mutiertem, nicht-kleinzelligem Lungenkarzinom im Stadium III, die nach definitiver Radiochemotherapie progressionsfrei sind. Auf der ASCO-Tagung wurden diese beeindruckenden Ergebnisse besprochen.

Hodgkin Lymphom: BrECADD-Regime übertrifft die Erwartungen

05.06.2024 ASCO 2024 Kongressbericht

Das Kombinationsregime BrECADD mit Brentuximab vedotin ermöglichte in der Studie HD21 beim fortgeschrittenen klassischen Hodgkin-Lymphom eine unerwartet hohe progressionsfreie Überlebensrate von 94,3% nach vier Jahren. Gleichzeitig war das Regime besser tolerabel als der bisherige Standard eBEACOPP.

Antikörper-Drug-Konjugat verdoppelt PFS bei Multiplem Myelom

05.06.2024 ASCO 2024 Nachrichten

Zwei Phase-3-Studien deuten auf erhebliche Vorteile des Antikörper-Wirkstoff-Konjugats Belantamab-Mafodotin bei vorbehandelten Personen mit Multiplem Myelom: Im Vergleich mit einer Standard-Tripeltherapie wurde das progressionsfreie Überleben teilweise mehr als verdoppelt.

Neuer TKI gegen CML: Höhere Wirksamkeit, seltener Nebenwirkungen

05.06.2024 Chronische myeloische Leukämie Nachrichten

Der Tyrosinkinasehemmer (TKI) Asciminib ist älteren Vertretern dieser Gruppe bei CML offenbar überlegen: Personen mit frisch diagnostizierter CML entwickelten damit in einer Phase-3-Studie häufiger eine gute molekulare Response, aber seltener ernste Nebenwirkungen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.